Knowledge Center

Four supply chain risk management firms presented their analytics and intelligence platforms, showcasing capabilities such as global monitoring, real-time alerts, logistics impact assessment, and visibility into upstream supply chain tiers.

The U.S. health care system relies heavily on a global supply chain for pharmaceuticals and medical devices. A significant portion of active pharmaceutical ingredients (APIs), especially for generic sterile injectables like chemotherapy drugs and antibiotics, are sourced from India and China. Similarly, complex medical devices often incorporate components from numerous countries. This global interdependence makes the health care sector particularly vulnerable to tariff-related disruptions.